These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. Schweppe RE; Klopper JP; Korch C; Pugazhenthi U; Benezra M; Knauf JA; Fagin JA; Marlow LA; Copland JA; Smallridge RC; Haugen BR J Clin Endocrinol Metab; 2008 Nov; 93(11):4331-41. PubMed ID: 18713817 [TBL] [Abstract][Full Text] [Related]
4. "Thyroid cancer" cell line misidentification: a time for proactive change. Ringel MD J Clin Endocrinol Metab; 2008 Nov; 93(11):4226-7. PubMed ID: 18987282 [No Abstract] [Full Text] [Related]
5. Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene. Nord B; Larsson C; Wong FK; Wallin G; Teh BT; Zedenius J Genes Chromosomes Cancer; 1999 Sep; 26(1):35-9. PubMed ID: 10441003 [TBL] [Abstract][Full Text] [Related]
6. Expansion of microsatellite in the thyroid hormone receptor-alpha1 gene linked to increased receptor expression and less aggressive thyroid cancer. Onda M; Li D; Suzuki S; Nakamura I; Takenoshita S; Brogren CH; Stampanoni S; Rampino N Clin Cancer Res; 2002 Sep; 8(9):2870-4. PubMed ID: 12231529 [TBL] [Abstract][Full Text] [Related]
7. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. Cavaco BM; Batista PF; Sobrinho LG; Leite V J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515 [TBL] [Abstract][Full Text] [Related]
8. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population. Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077 [TBL] [Abstract][Full Text] [Related]
9. Detection of activated ras oncogenes in human thyroid carcinomas. Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656 [TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Powell N; Dudley E; Morishita M; Bogdanova T; Tronko M; Thomas G Rapid Commun Mass Spectrom; 2004; 18(19):2249-54. PubMed ID: 15384144 [TBL] [Abstract][Full Text] [Related]
12. Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582. Lima J; Máximo V; Soares P; Williams D; Bogdanova T; Thomas GA; Sobrinho-Simões M Carcinogenesis; 2003 Jun; 24(6):1155. PubMed ID: 12807747 [No Abstract] [Full Text] [Related]
13. Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer. Alzahrani AS; Murugan AK; Qasem E; Alswailem MM; AlGhamdi B; Moria Y; Al-Hindi H Endocrine; 2019 Jan; 63(1):94-100. PubMed ID: 30269267 [TBL] [Abstract][Full Text] [Related]
14. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling. Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359 [TBL] [Abstract][Full Text] [Related]
15. [BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma]. Cañadas Garre M; López de la Torre Casares M; Becerra Massare P; López Nevot MÁ; Villar Del Moral J; Muñoz Pérez N; Vílchez Joya R; Montes Ramírez R; Llamas Elvira JM Endocrinol Nutr; 2011 Apr; 58(4):175-84. PubMed ID: 21441079 [TBL] [Abstract][Full Text] [Related]